Concepedia

Jeany M. Rademaker-Lakhai

JM

11

Publications

1.6K

Citations

11

H-Index

2002

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Utrecht University

Slotervaartziekenhuis

Oncode Institute

PharmaMar (Spain)

Jeany M. Rademaker-Lakhai is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2002–2018

11

Publications

11

A Phase I and Pharmacological Study with Imidazolium-<b> <i>trans-</i> </b>DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

Jeany M. Rademaker-Lakhai, H.J.G.D. van den Bongard, Dick Pluim et al. · Clinical Cancer Research · 2004 · 820 citations · Full text

A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors

Jeany M. Rademaker-Lakhai, C. Terret, Stephen B. Howell et al. · Clinical Cancer Research · 2004 · 210 citations

Relationship Between Cisplatin Administration and the Development of Ototoxicity

Jeany M. Rademaker-Lakhai, Mirjam Crul, Lot C. Zuur et al. · Journal of Clinical Oncology · 2006 · 170 citations · Full text

Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients

Mario Campone, Jeany M. Rademaker-Lakhai, Jaafar Bennouna et al. · Cancer Chemotherapy and Pharmacology · 2007 · 111 citations

, , +7

Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer

Jeany M. Rademaker-Lakhai, Simon Horenblas, W. Meinhardt et al. · Clinical Cancer Research · 2005 · 86 citations

Rows per page

1–5 of 11